ADRs Achieve General Monday; AstraZeneca‘s ADRs Weaken After Vaccine Information
By Micah Maidenberg
The S&P/BNY Mellon index of American depositary receipts gained 0.9% Monday to 148.89. The European index closed at 121.61, 0.7% greater. The emerging-markets and the Asian indices rose 1.2% and 1.1%, respectively, closing at 392.17 and 221.5. The index for Latin American ADRs elevated 1.6% to 392.17.
AstraZeneca PLC’s American depositary receipts ended down 1.1%. AstraZeneca and the College of Oxford mentioned Monday their Covid-19 vaccine was efficient as a lot as 90% of the time in stopping infections with out main unwanted effects. Moderna Inc. has additionally developed a vaccine, as have Pfizer Inc. and Germany’s BioNTech SE, whereas China and Russia have deployed their very own vaccines to fight Covid-19.
ADRs for gold producers fell in tandem with decrease costs for the dear metallic on Monday. Gold Fields Ltd. receipts had been off nearly 5% to $9.17 whereas Concord Gold Mining Co.’s dropped 7.3% to $4.32. AngloGold Ashanti Ltd.’s ADR fell 4.7% to $21.51.
Write to Micah Maidenberg at email@example.com
(END) Dow Jones Newswires
November 23, 2020 17:01 ET (22:01 GMT)
Copyright (c) 2020 Dow Jones & Firm, Inc.
Market information on CNN.